Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | AMGN | BMY | VRTX | GILD |
| Company | Novocure Ltd Ord Sh | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.97 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 17.17 | 290.57 | 58.48 | 455.43 | 89.94 |
| Low | 16.30 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 17.05 | 290.13 | 58.29 | 450.19 | 89.50 |
| Change | +0.19 | +2.26 | +0.41 | -1.04 | +0.87 |
| % Change | +1.13% | +0.79% | +0.71% | -0.23% | +0.98% |
| Volume | 480,546 | 1,651,848 | 4,164,803 | 782,503 | 1,994,619 |
| 20-Day Average Volume | 894,882 | 2,824,186 | 12,224,197 | 1,307,496 | 7,421,928 |
| Previous Close | 16.86 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.88 | 307.41 | 55.93 | 479.18 | 90.88 |
| 20-Day Raw Stochastic | 53.22% | 26.74% | 70.98% | 5.51% | 27.61% |
| 20-Day Relative Strength | 51.05% | 36.30% | 61.06% | 40.58% | 53.28% |
| Weighted Alpha | +13.93 | +1.80 | +26.52 | +17.65 | +25.80 |
| Today's Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 40% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.60% since 11/14/24 | -2.12% since 11/14/24 | -0.19% since 11/14/24 | -7.17% since 11/14/24 | -2.70% since 11/14/24 |
| Low | 15.35 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 17.35 on 11/20/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +4.49% since 10/21/24 | -8.55% since 10/21/24 | +12.03% since 10/21/24 | -6.03% since 10/21/24 | +3.86% since 10/21/24 |
| Low | 15.10 on 11/01/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 18.67 on 11/08/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -2.86% since 08/21/24 | -12.00% since 08/21/24 | +20.54% since 08/21/24 | -7.58% since 08/21/24 | +19.29% since 08/21/24 |
| Low | 14.17 on 10/08/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 21.82 on 10/16/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -25.27% since 05/21/24 | -8.00% since 05/21/24 | +38.14% since 05/21/24 | +1.64% since 05/21/24 | +33.18% since 05/21/24 |
| Low | 14.17 on 10/08/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 24.40 on 06/04/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,824,269 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 108,201 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 509,340,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -207,040,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 155,100,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -30,570,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.71 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 10/30/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/30/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |